WRF Capital is the venture investment vehicle of the Washington Research Foundation. See contact routes.
WRF Capital is the venture investment vehicle of the Washington Research Foundation, a Seattle-based nonprofit founded in 1981 that commercializes university research. The firm specializes in early-stage venture capital, investing primarily in Washington-based companies and spinouts from the state’s nonprofit research institutions. Its investment thesis targets the life sciences, information technology, and physical sciences sectors, with a strict geographic focus on Washington State. Typical check sizes and lead/follow behavior are not publicly disclosed in available sources, though the firm has made 52 investments as of March 2020. Notable portfolio companies include AbSci, A-Alpha Bio, Faraday Pharmaceuticals, and AAVogen, with major exits such as Alder Biopharmaceuticals, Omeros, and CSATS. WRF Capital’s distinctive point of view centers on enabling the transition of academic research into commercially viable enterprises, emphasizing life-changing innovations in life sciences and enabling technologies.
Details on this firm come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Seattle.
Investors like WRF Capital · Full investor directory · Investor access · Company funding database